| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |